ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 35 filers reported holding ENOCHIAN BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $94,777 | +1213.6% | 21,203 | +66.5% | 0.00% | – |
Q2 2023 | $7,215 | -38.1% | 12,734 | -0.1% | 0.00% | – |
Q1 2023 | $11,660 | +89592.3% | 12,742 | -0.1% | 0.00% | – |
Q4 2022 | $13 | -100.0% | 12,754 | -37.6% | 0.00% | – |
Q3 2022 | $37,000 | -66.7% | 20,442 | -64.5% | 0.00% | – |
Q2 2022 | $111,000 | -79.7% | 57,545 | -13.4% | 0.00% | – |
Q1 2022 | $548,000 | -6.8% | 66,431 | -17.7% | 0.00% | – |
Q4 2021 | $588,000 | +8.3% | 80,675 | 0.0% | 0.00% | – |
Q3 2021 | $543,000 | +35.1% | 80,675 | -0.2% | 0.00% | – |
Q2 2021 | $402,000 | +33.6% | 80,825 | -4.8% | 0.00% | – |
Q1 2021 | $301,000 | +59.3% | 84,921 | +32.4% | 0.00% | – |
Q4 2020 | $189,000 | -17.8% | 64,149 | +0.0% | 0.00% | – |
Q3 2020 | $230,000 | -14.8% | 64,141 | 0.0% | 0.00% | – |
Q2 2020 | $270,000 | +40.6% | 64,141 | 0.0% | 0.00% | – |
Q1 2020 | $192,000 | -38.3% | 64,141 | +3.4% | 0.00% | – |
Q4 2019 | $311,000 | -13.4% | 62,041 | -5.1% | 0.00% | – |
Q3 2019 | $359,000 | +22.1% | 65,341 | 0.0% | 0.00% | – |
Q2 2019 | $294,000 | +297.3% | 65,341 | +514.2% | 0.00% | – |
Q1 2019 | $74,000 | – | 10,638 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
Ergoteles LLC | 47,984 | $238,000 | 0.01% |
Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
UBS Group AG | 260 | $1,000 | 0.00% |